Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥60ml/min per 1.73m2

AIDS

Volumn 27, Issue 8, 2013, Pages 1295-1302

  Reynes, Jacques ^a,b   Cournil, Amandine ^b   Peyriere, Hélène ^b   Psomas, Christina ^a   Guiller, Elsa ^a   Chatron, Marlène ^a   Cristol, Jean Paul ^a,c   Badiou, Stéphanie ^a,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c University Montpellier 1 et 2   (France)

Author keywords

Albuminuria; Glomerulopathy; HIV; Proteinuria; Tenofovir; Tubular proteinuria

Indexed keywords

ALBUMIN; CREATININE; TENOFOVIR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET; FEMALE; GLOMERULAR PROTEINURIA; GLOMERULUS FILTRATION RATE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; TUBULAR PROTEINURIA;

ADENINE; ADULT; AGED; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; PROTEINURIA; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84879082754     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835fac51     Document Type: Article

References (42)

1. Gupta SK, Eustace JA, Winston J.A., Boydstun II, Ahuja TS, Rodriguez RA, et al Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-1585.
2. Winston J, Deray G, Hawkins T., Szczech L, Wyatt C, Young B., et al. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis 2008; 47:1449-1457.
3. Winston JA. HIV and CKD epidemiology. Adv Chronic Kidney Dis 2010; 17:19-25.
4. Choi AI, Li Y, Deeks S.G., Grunfeld Y., Volberding PA, Shlipak MG, et al Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010; 121:651-658.
5. George E, Lucas GM, Nadkarni G.N., Fine DM, Moore R, Atta MG, et al Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS 2010; 24:387-394.
6. Fernando SK, Finkelstein FO, Moore B.A., Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci 2008; 335:89-94.
7. Peyriere H, Reynes J, Rouanet I., Daniel N, de Boever CM, Mauboussin JM, et al. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr 2004; 35:269-273.
8. Scherzer R, Estrella M, Li Y., Choi AI, Deeks SG, Grunfeld C, et al Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS 2012; 26:867-875.
9. Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J., et al. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS 2009; 23:689-696.
10. Hall AM, Hendry BM, Nitsch D, Connolly JO Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 2011; 57:773-870.
11. Ando M, Yanagisawa N, Ajisawa A., Tsuchiya K, Nitta K. Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant 2011; 26:3224-3229.
12. Badiou S, De Boever CM, Terrier N, Baillat V, Cristol J.P., Reynes J. Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults? J Infect 2006; 52:335-338.
13. Cooper RD, Wiebe N, Smith N., Keiser P, Naicker S, Tonelli M., et al. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis 2010; 51:496-505.
14. Mocroft A, Kirk O, Reiss P., De Wit S, Sedlacek D, Beniowski M., et al., EuroSIDA Study Group. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010; 24:1667-1678.
15. Cooper RD, Tonelli M. Renal disease associated with antiretroviral therapy in the treatment of HIV. Nephron Clin Pract 2011; 118:c262-c268.
16. Samarawickrama A, Cai M, Smith E., Nambiar K, Sabin C, Fisher M., et al. Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria. HIV Med 2012; 13:526-532.
17. Pugliese P, Cuzin L, Cabié A, Poizot-Martin I, Allavena C, Duvivier C, et al., Nadis Group. A large French prospective cohort of HIV-infected patients: the Nadis Cohort. HIV Med 2009; 10:504-511.
18. European AIDS case definition. Commun Dis Rep CDR Wkly 1993; 3:141.
19. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1197.
20. Piéroni L., Delanaye P, Boutten A., Bargnoux AS, Rozet E, Delatour V, et al A multicentric evaluation of IDMS-traceable creatinine enzymatic assays. Clin Chim Acta 2011; 412:2070-2075.
21. Levey AS, Bosch JP, Lewis J.B., Levey AS, Greene T, Rogers N, et al A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130:461-470.
22. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
23. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80:17-28.
24. Smith ER, Cai MM, McMahon L.P., Wright DA, Holt SG The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant 2012; 27:1534-1541.
25. Sumaili EK, Cohen EP, Zinga C.V., Krzesinski JM, Pakasa NM, Nseka NM High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol 2009; 10:18.
26. Cailhol J, Nkurunziza B, Izzedine H., Nindagiye E, Munyana L, Baramperanye E., et al. Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study. BMC Nephrol 2011; 12:40.
27. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379:165-180.
28. Brown TT, Cole SR, Li X, Kingsley L.A., Palella FJ, Riddler SA, et al Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165:1179-1184.
29. Déti E.K., Thiébaut R, Bonnet F., Lawson-Ayayi S, Dupon M, Neau D., et al. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. HIV Med 2010; 11:308-317.
30. Dauchy FA, Lawson-Ayayi S, de La Faille R, Bonnet F, Rigothier C, Mehsen N, et al. Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy. Kidney Int 2011; 80:302-309.
31. Mocroft A, Kirk O, Gatell J., Reiss P, Gargalianos P, Zilmer K., et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21:1119-1127.
32. Kim PS, Woods C, Dutcher L., Georgoff P, Rosenberg A, Mican J.A., et al. Increased prevalence of albuminuria in HIV-infected adults with diabetes. PLoS One 2011; 6:e24610.
33. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS 2005; 19:93-95.
34. Kohler JJ, Hosseini SH, Green E, Abuin A., Ludaway T, Russ R, et al Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters. Lab Invest 2011; 91:852-858.
35. Wyatt CM, Malvestutto C, Coca S.G., Klotman PE, Parikh CR The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS 2008; 22:1799-1807.
36. Praga M, Gutiérrez Solís E, Morales E. Hepatitis C-induced renal disease in patients with AIDS: an emergent problem. Contrib Nephrol 2012; 176:24-34.
37. Wever K, van Agtmael MA, Carr A. Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. J Acquir Immune Defic Syndr 2010; 55:78-81.
38. Aros C, Remuzzi G. The renin-angiotensin system in progression, remission, and regression of chronic nephropathies. J Hypertens 2002; 20 (SUPPL. 3):S45-S53.
39. Ucciferri C, Falasca K, Mancino P., Di Iorio A, Vecchiet J. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. Eur Rev Med Pharmacol Sci 2012; 16:491-498.
40. Rodríguez-Nóvoa S, Labarga P, D'Avolio A, Barreiro P, Albalate M, Vispo E, et al. Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS 2010; 24:1064-1066.
41. Post FA, Wyatt CM, Mocroft A. Biomarkers of impaired renal function. Curr Opin HIV AIDS 2010; 5:524-530.
42. Jaafar A, Séronie-Vivien S, Malard L, Massip P, Chatelut E, Tack I. Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients. AIDS 2009; 23:257-259.